Concepedia

Author

Pengfei Jin

Jiangsu Provincial Center for Disease Control and PreventionORCID

Also Known As

Jin, Peng-Fei, Jin, Pengfei, P F Jin, Peng-Fei Jin, Peng-fei Jin, Pengfei Jin

69

Publications

762

Citations

12

H-Index

21

Concepts

All Affiliations

Jiangsu Provincial Center for Disease Control and PreventionSoutheast UniversityCanSino (China)Nanjing Medical UniversityAcademy of Military Medical Sciences
PJ

About

Pengfei Jin is an author at Jiangsu Provincial Center for Disease Control and Prevention specializing in medicine, vaccine efficacy, and public health.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

45

2

Public Health

1

1

33

3

Epidemiology

1

1

33

4

Immunology

1

1

33

5

Pathology

1

1

12

Pengfei Jin

×

13

Publications

561

Citations

12

H-Index

YearCitations

Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial

Jingxin Li, Lihua Hou, Xiling Guo,

Nature Medicine

2022

158

Safety and Immunogenicity of a Recombinant Adenovirus Type-5–Vectored Coronavirus Disease 2019 (COVID-19) Vaccine With a Homologous Prime-Boost Regimen in Healthy Participants Aged ≥6 Years: A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Trial

Fengcai Zhu, Pengfei Jin, Tao Zhu,

Clinical Infectious Diseases

2021

102

Comparison of the Effects of Laparoscopic Hernia Repair and Lichtenstein Tension-Free Hernia Repair

Weijun Wang, Jun-zhen Chen, Qian Fang,

Journal of Laparoendoscopic & Advanced Surgical Techniques

2013

80

Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial

Pengfei Jin, Xiling Guo, Wei Chen,

PLoS Medicine

2022

44

STAT3 regulated <i>miR-216a</i> promotes ovarian cancer proliferation and cisplatin resistance

Pengfei Jin, Yan‐Jun Liu, Ruijuan Wang

Bioscience Reports

2018

41

Heterologous prime-boost immunization with CoronaVac and Convidecia

Jingxin Li, Lihua Hou, Xiling Guo,

2021

33

Validation and evaluation of serological correlates of protection for inactivated enterovirus 71 vaccine in children aged 6-35 months

Pengfei Jin, Jingxin Li, Xuefeng Zhang,

Human Vaccines & Immunotherapeutics

2016

24

Correlates of protection for inactivated enterovirus 71 vaccine: the analysis of immunological surrogate endpoints

Wenbo Zhu, Pengfei Jin, Jingxin Li,

Expert Review of Vaccines

2017

17

&lt;p&gt;DPY30 regulates cervical squamous cell carcinoma by mediating epithelial–mesenchymal transition (EMT)&lt;/p&gt;

Fengxi He, Lili Zhang, Pengfei Jin,

OncoTargets and Therapy

2019

16

Clinicopathological and prognostic significance of aberrant G protein-couple receptor 110 (GPR110) expression in gastric cancer

Xiaolian Zhu, Guoqiang Huang, Pengfei Jin

Pathology - Research and Practice

2018

12

Page 1